Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease

American Journal of Cardiology

Volumn 118, Issue 1, 2016, Pages 138-145

  Budoff, Matthew ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; CARNITINE PALMITOYLTRANSFERASE I; CHYLOMICRON; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY RISK; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; GENE LOCUS; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LOSS OF FUNCTION MUTATION; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS (TOPIC); PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR DISEASES; PHYSIOLOGY;

CARDIOVASCULAR DISEASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPOPROTEINS; MENDELIAN RANDOMIZATION ANALYSIS; TRIGLYCERIDES;

EID: 84966696711     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.04.004     Document Type: Conference Paper

References (55)

1. A.C. Boullart, G.J. de, and A.F. Stalenhoef Serum triglycerides and risk of cardiovascular disease Biochim Biophys Acta 1821 2012 867 875
2. M. Miller, N.J. Stone, C. Ballantyne, V. Bittner, M.H. Criqui, H.N. Ginsberg, A.C. Goldberg, W.J. Howard, M.S. Jacobson, P.M. Kris-Etherton, T.A. Lennie, M. Levi, T. Mazzone, and S. Pennathur Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2011 2292 2333
3. S.A. Khetarpal, and D.J. Rader Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics Arterioscler Thromb Vasc Biol 35 2015 e3 e9
4. H. Wang, and R.H. Eckel Lipoprotein lipase: from gene to obesity Am J Physiol Endocrinol Metab 297 2009 E271 E288
5. T.A. Jacobson, M.K. Ito, K.C. Maki, C.E. Orringer, H.E. Bays, P.H. Jones, J.M. McKenney, S.M. Grundy, E.A. Gill, R.A. Wild, D.P. Wilson, and W.V. Brown National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary J Clin Lipidol 8 2014 473 488
6. H.T. May, J.R. Nelson, S.T. Lirette, K.R. Kulkarni, J.L. Anderson, M.E. Griswold, B.D. Horne, A. Correa, and J.B. Muhlestein The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: the Jackson Heart Study Eur J Prev Cardiol 23 2016 769 776
7. T.I. Pollin, C.M. Damcott, H. Shen, S.H. Ott, J. Shelton, R.B. Horenstein, W. Post, J.C. McLenithan, L.F. Bielak, P.A. Peyser, B.D. Mitchell, M. Miller, J.R. O'Connell, and A.R. Shuldiner A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection Science 322 2008 1702 1705
8. A.B. Jorgensen, R. Frikke-Schmidt, B.G. Nordestgaard, and A. Tybjaerg-Hansen Loss-of-function mutations in APOC3 and risk of ischemic vascular disease N Engl J Med 371 2014 32 41
9. J. Crosby, G.M. Peloso, P.L. Auer, D.R. Crosslin, N.O. Stitziel, L.A. Lange, Y. Lu, Z.Z. Tang, H. Zhang, G. Hindy, N. Masca, K. Stirrups, S. Kanoni, R. Do, G. Jun, Y. Hu, H.M. Kang, C. Xue, A. Goel, M. Farrall, S. Duga, P.A. Merlini, R. Asselta, D. Girelli, O. Olivieri, N. Martinelli, W. Yin, D. Reilly, E. Speliotes, C.S. Fox, K. Hveem, O.L. Holmen, M. Nikpay, D.N. Farlow, T.L. Assimes, N. Franceschini, J. Robinson, K.E. North, L.W. Martin, M. DePristo, N. Gupta, S.A. Escher, J.H. Jansson, Z.N. Van, C.N. Palmer, N. Wareham, W. Koch, T. Meitinger, A. Peters, W. Lieb, R. Erbel, I.R. Konig, J. Kruppa, F. Degenhardt, O. Gottesman, E.P. Bottinger, C.J. O'Donnell, B.M. Psaty, C.M. Ballantyne, G. Abecasis, J.M. Ordovas, O. Melander, H. Watkins, M. Orho-Melander, D. Ardissino, R.J. Loos, R. McPherson, C.J. Willer, J. Erdmann, A.S. Hall, N.J. Samani, P. Deloukas, H. Schunkert, J.G. Wilson, C. Kooperberg, S.S. Rich, R.P. Tracy, D.Y. Lin, D. Altshuler, S. Gabriel, D.A. Nickerson, G.P. Jarvik, L.A. Cupples, A.P. Reiner, E. Boerwinkle, and S. Kathiresan Loss-of-function mutations in APOC3, triglycerides, and coronary disease N Engl J Med 371 2014 22 31
10. P. Natarajan, P. Kohli, U. Baber, K.D. Nguyen, S. Sartori, D.F. Reilly, R. Mehran, P. Muntendam, V. Fuster, D.J. Rader, and S. Kathiresan Association of APOC3 loss-of-function mutations with plasma lipids and subclinical atherosclerosis J Am Coll Cardiol 66 2015 2053 2055
11. R. Do, N.O. Stitziel, H.H. Won, A.B. Jorgensen, S. Duga, M.P. Angelica, A. Kiezun, M. Farrall, A. Goel, O. Zuk, I. Guella, R. Asselta, L.A. Lange, G.M. Peloso, P.L. Auer, D. Girelli, N. Martinelli, D.N. Farlow, M.A. DePristo, R. Roberts, A.F. Stewart, D. Saleheen, J. Danesh, S.E. Epstein, S. Sivapalaratnam, G.K. Hovingh, J.J. Kastelein, N.J. Samani, H. Schunkert, J. Erdmann, S.H. Shah, W.E. Kraus, R. Davies, M. Nikpay, C.T. Johansen, J. Wang, R.A. Hegele, E. Hechter, W. Marz, M.E. Kleber, J. Huang, A.D. Johnson, M. Li, G.L. Burke, M. Gross, Y. Liu, T.L. Assimes, G. Heiss, E.M. Lange, A.R. Folsom, H.A. Taylor, O. Olivieri, A. Hamsten, R. Clarke, D.F. Reilly, W. Yin, M.A. Rivas, P. Donnelly, J.E. Rossouw, B.M. Psaty, D.M. Herrington, J.G. Wilson, S.S. Rich, M.J. Bamshad, R.P. Tracy, L.A. Cupples, D.J. Rader, M.P. Reilly, J.A. Spertus, S. Cresci, J. Hartiala, W.H. Tang, S.L. Hazen, H. Allayee, A.P. Reiner, C.S. Carlson, C. Kooperberg, R.D. Jackson, E. Boerwinkle, E.S. Lander, S.M. Schwartz, D.S. Siscovick, R. McPherson, A. Tybjaerg-Hansen, G.R. Abecasis, H. Watkins, D.A. Nickerson, D. Ardissino, S.R. Sunyaev, C.J. O'Donnell, D. Altshuler, S. Gabriel, and S. Kathiresan Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction Nature 518 2015 102 106
12. N. Sarwar, M.S. Sandhu, S.L. Ricketts, A.S. Butterworth, A.E. Di, S.M. Boekholdt, W. Ouwehand, H. Watkins, N.J. Samani, D. Saleheen, D. Lawlor, M.P. Reilly, A.D. Hingorani, P.J. Talmud, and J. Danesh Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies Lancet 375 2010 1634 1639
13. F.E. Dewey, V. Gusarova, C. O'Dushlaine, O. Gottesman, J. Trejos, C. Hunt, C.V. Van Hout, L. Habegger, D. Buckler, K.M.V. Lai, J.B. Leader, M.F. Murray, M.D. Ritchie, H.L. Kirchner, D.H. Ledbetter, J. Penn, A. Lopez, I.B. Borecki, J.D. Overton, J.G. Reid, D.J. Carey, A.J. Murphy, G.D. Yancopoulos, A. Baras, J. Gromada, and A.R. Shuldiner Inactivating variants in ANGPTL4 and risk of coronary artery disease N Engl J Med 374 2016 1123 1133
14. N. Stitziel, K. Stirrups, N. Masca, J. Erdmann, S. Kathiresan, P. Deloukas, N.J. Samani, and H. Schunkert Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease N Engl J Med 374 2016 1134 1144
15. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, M. Koseki, J.P. Pirruccello, S. Ripatti, D.I. Chasman, C.J. Willer, C.T. Johansen, S.W. Fouchier, A. Isaacs, G.M. Peloso, M. Barbalic, S.L. Ricketts, J.C. Bis, Y.S. Aulchenko, G. Thorleifsson, M.F. Feitosa, J. Chambers, M. Orho-Melander, O. Melander, T. Johnson, X. Li, X. Guo, M. Li, C.Y. Shin, G.M. Jin, K.Y. Jin, J.Y. Lee, T. Park, K. Kim, X. Sim, O.R. Twee-Hee, D.C. Croteau-Chonka, L.A. Lange, J.D. Smith, K. Song, Z.J. Hua, X. Yuan, J. Luan, C. Lamina, A. Ziegler, W. Zhang, R.Y. Zee, A.F. Wright, J.C. Witteman, J.F. Wilson, G. Willemsen, H.E. Wichmann, J.B. Whitfield, D.M. Waterworth, N.J. Wareham, G. Waeber, P. Vollenweider, B.F. Voight, V. Vitart, A.G. Uitterlinden, M. Uda, J. Tuomilehto, J.R. Thompson, T. Tanaka, I. Surakka, H.M. Stringham, T.D. Spector, N. Soranzo, J.H. Smit, J. Sinisalo, K. Silander, E.J. Sijbrands, A. Scuteri, J. Scott, D. Schlessinger, S. Sanna, V. Salomaa, J. Saharinen, C. Sabatti, A. Ruokonen, I. Rudan, L.M. Rose, R. Roberts, M. Rieder, B.M. Psaty, P.P. Pramstaller, I. Pichler, M. Perola, B.W. Penninx, N.L. Pedersen, C. Pattaro, A.N. Parker, G. Pare, B.A. Oostra, C.J. O'Donnell, M.S. Nieminen, D.A. Nickerson, G.W. Montgomery, T. Meitinger, R. McPherson, M.I. McCarthy, W. McArdle, D. Masson, N.G. Martin, F. Marroni, M. Mangino, P.K. Magnusson, G. Lucas, R. Luben, R.J. Loos, M.L. Lokki, G. Lettre, C. Langenberg, L.J. Launer, E.G. Lakatta, R. Laaksonen, K.O. Kyvik, F. Kronenberg, I.R. Konig, K.T. Khaw, J. Kaprio, L.M. Kaplan, A. Johansson, M.R. Jarvelin, A.C. Janssens, E. Ingelsson, W. Igl, H.G. Kees, J.J. Hottenga, A. Hofman, A.A. Hicks, C. Hengstenberg, I.M. Heid, C. Hayward, A.S. Havulinna, N.D. Hastie, T.B. Harris, T. Haritunians, A.S. Hall, U. Gyllensten, C. Guiducci, L.C. Groop, E. Gonzalez, C. Gieger, N.B. Freimer, L. Ferrucci, J. Erdmann, P. Elliott, K.G. Ejebe, A. Doring, A.F. Dominiczak, S. Demissie, P. Deloukas, E.J. de Geus, U. de Faire, G. Crawford, F.S. Collins, Y.D. Chen, M.J. Caulfield, H. Campbell, N.P. Burtt, L.L. Bonnycastle, D.I. Boomsma, S.M. Boekholdt, R.N. Bergman, I. Barroso, S. Bandinelli, C.M. Ballantyne, T.L. Assimes, T. Quertermous, D. Altshuler, M. Seielstad, T.Y. Wong, E.S. Tai, A.B. Feranil, C.W. Kuzawa, L.S. Adair, H.A. Taylor Jr., I.B. Borecki, S.B. Gabriel, J.G. Wilson, H. Holm, U. Thorsteinsdottir, V. Gudnason, R.M. Krauss, K.L. Mohlke, J.M. Ordovas, P.B. Munroe, J.S. Kooner, A.R. Tall, R.A. Hegele, J.J. Kastelein, E.E. Schadt, J.I. Rotter, E. Boerwinkle, D.P. Strachan, V. Mooser, K. Stefansson, M.P. Reilly, N.J. Samani, H. Schunkert, L.A. Cupples, M.S. Sandhu, P.M. Ridker, D.J. Rader, C.M. van Duijn, L. Peltonen, G.R. Abecasis, M. Boehnke, and S. Kathiresan Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
16. H. Schunkert, I.R. Konig, S. Kathiresan, M.P. Reilly, T.L. Assimes, H. Holm, M. Preuss, A.F. Stewart, M. Barbalic, C. Gieger, D. Absher, Z. Aherrahrou, H. Allayee, D. Altshuler, S.S. Anand, K. Andersen, J.L. Anderson, D. Ardissino, S.G. Ball, A.J. Balmforth, T.A. Barnes, D.M. Becker, L.C. Becker, K. Berger, J.C. Bis, S.M. Boekholdt, E. Boerwinkle, P.S. Braund, M.J. Brown, M.S. Burnett, I. Buysschaert, J.F. Carlquist, L. Chen, S. Cichon, V. Codd, R.W. Davies, G. Dedoussis, A. Dehghan, S. Demissie, J.M. Devaney, P. Diemert, R. Do, A. Doering, S. Eifert, N.E. Mokhtari, S.G. Ellis, R. Elosua, J.C. Engert, S.E. Epstein, U. de Faire, M. Fischer, A.R. Folsom, J. Freyer, B. Gigante, D. Girelli, S. Gretarsdottir, V. Gudnason, J.R. Gulcher, E. Halperin, N. Hammond, S.L. Hazen, A. Hofman, B.D. Horne, T. Illig, C. Iribarren, G.T. Jones, J.W. Jukema, M.A. Kaiser, L.M. Kaplan, J.J. Kastelein, K.T. Khaw, J.W. Knowles, G. Kolovou, A. Kong, R. Laaksonen, D. Lambrechts, K. Leander, G. Lettre, M. Li, W. Lieb, C. Loley, A.J. Lotery, P.M. Mannucci, S. Maouche, N. Martinelli, P.P. McKeown, C. Meisinger, T. Meitinger, O. Melander, P.A. Merlini, V. Mooser, T. Morgan, T.W. Muhleisen, J.B. Muhlestein, T. Munzel, K. Musunuru, J. Nahrstaedt, C.P. Nelson, M.M. Nothen, O. Olivieri, R.S. Patel, C.C. Patterson, A. Peters, F. Peyvandi, L. Qu, A.A. Quyyumi, D.J. Rader, L.S. Rallidis, C. Rice, F.R. Rosendaal, D. Rubin, V. Salomaa, M.L. Sampietro, M.S. Sandhu, E. Schadt, A. Schafer, A. Schillert, S. Schreiber, J. Schrezenmeir, S.M. Schwartz, D.S. Siscovick, M. Sivananthan, S. Sivapalaratnam, A. Smith, T.B. Smith, J.D. Snoep, N. Soranzo, J.A. Spertus, K. Stark, K. Stirrups, M. Stoll, W.H. Tang, S. Tennstedt, G. Thorgeirsson, G. Thorleifsson, M. Tomaszewski, A.G. Uitterlinden, A.M. van Rij, B.F. Voight, N.J. Wareham, G.A. Wells, H.E. Wichmann, P.S. Wild, C. Willenborg, J.C. Witteman, B.J. Wright, S. Ye, T. Zeller, A. Ziegler, F. Cambien, A.H. Goodall, L.A. Cupples, T. Quertermous, W. Marz, C. Hengstenberg, S. Blankenberg, W.H. Ouwehand, A.S. Hall, P. Deloukas, J.R. Thompson, K. Stefansson, R. Roberts, U. Thorsteinsdottir, C.J. O'Donnell, R. McPherson, J. Erdmann, and N.J. Samani Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat Genet 43 2011 333 338
17. C.J. Willer, E.M. Schmidt, S. Sengupta, G.M. Peloso, S. Gustafsson, S. Kanoni, A. Ganna, J. Chen, M.L. Buchkovich, S. Mora, J.S. Beckmann, J.L. Bragg-Gresham, H.Y. Chang, A. Demirkan, H.M. Den Hertog, R. Do, L.A. Donnelly, G.B. Ehret, T. Esko, M.F. Feitosa, T. Ferreira, K. Fischer, P. Fontanillas, R.M. Fraser, D.F. Freitag, D. Gurdasani, K. Heikkila, E. Hypponen, A. Isaacs, A.U. Jackson, A. Johansson, T. Johnson, M. Kaakinen, J. Kettunen, M.E. Kleber, X. Li, J. Luan, L.P. Lyytikainen, P.K. Magnusson, M. Mangino, E. Mihailov, M.E. Montasser, M. Muller-Nurasyid, I.M. Nolte, J.R. O'Connell, C.D. Palmer, M. Perola, A.K. Petersen, S. Sanna, R. Saxena, S.K. Service, S. Shah, D. Shungin, C. Sidore, C. Song, R.J. Strawbridge, I. Surakka, T. Tanaka, T.M. Teslovich, G. Thorleifsson, E.G. Van den Herik, B.F. Voight, K.A. Volcik, L.L. Waite, A. Wong, Y. Wu, W. Zhang, D. Absher, G. Asiki, I. Barroso, L.F. Been, J.L. Bolton, L.L. Bonnycastle, P. Brambilla, M.S. Burnett, G. Cesana, M. Dimitriou, A.S. Doney, A. Doring, P. Elliott, S.E. Epstein, G.I. Eyjolfsson, B. Gigante, M.O. Goodarzi, H. Grallert, M.L. Gravito, C.J. Groves, G. Hallmans, A.L. Hartikainen, C. Hayward, D. Hernandez, A.A. Hicks, H. Holm, Y.J. Hung, T. Illig, M.R. Jones, P. Kaleebu, J.J. Kastelein, K.T. Khaw, E. Kim, N. Klopp, P. Komulainen, M. Kumari, C. Langenberg, T. Lehtimaki, S.Y. Lin, J. Lindstrom, R.J. Loos, F. Mach, W.L. McArdle, C. Meisinger, B.D. Mitchell, G. Muller, R. Nagaraja, N. Narisu, T.V. Nieminen, R.N. Nsubuga, I. Olafsson, K.K. Ong, A. Palotie, T. Papamarkou, C. Pomilla, A. Pouta, D.J. Rader, M.P. Reilly, P.M. Ridker, F. Rivadeneira, I. Rudan, A. Ruokonen, N. Samani, H. Scharnagl, J. Seeley, K. Silander, A. Stancakova, K. Stirrups, A.J. Swift, L. Tiret, A.G. Uitterlinden, L.J. van Pelt, S. Vedantam, N. Wainwright, C. Wijmenga, S.H. Wild, G. Willemsen, T. Wilsgaard, J.F. Wilson, E.H. Young, J.H. Zhao, L.S. Adair, D. Arveiler, T.L. Assimes, S. Bandinelli, F. Bennett, M. Bochud, B.O. Boehm, D.I. Boomsma, I.B. Borecki, S.R. Bornstein, P. Bovet, M. Burnier, H. Campbell, A. Chakravarti, J.C. Chambers, Y.D. Chen, F.S. Collins, R.S. Cooper, J. Danesh, G. Dedoussis, U. de Faire, A.B. Feranil, J. Ferrieres, L. Ferrucci, N.B. Freimer, C. Gieger, L.C. Groop, V. Gudnason, U. Gyllensten, A. Hamsten, T.B. Harris, A. Hingorani, J.N. Hirschhorn, A. Hofman, G.K. Hovingh, C.A. Hsiung, S.E. Humphries, S.C. Hunt, K. Hveem, C. Iribarren, M.R. Jarvelin, A. Jula, M. Kahonen, J. Kaprio, A. Kesaniemi, M. Kivimaki, J.S. Kooner, P.J. Koudstaal, R.M. Krauss, D. Kuh, J. Kuusisto, K.O. Kyvik, M. Laakso, T.A. Lakka, L. Lind, C.M. Lindgren, N.G. Martin, W. Marz, M.I. McCarthy, C.A. McKenzie, P. Meneton, A. Metspalu, L. Moilanen, A.D. Morris, P.B. Munroe, I. Njolstad, N.L. Pedersen, C. Power, P.P. Pramstaller, J.F. Price, B.M. Psaty, T. Quertermous, R. Rauramaa, D. Saleheen, V. Salomaa, D.K. Sanghera, J. Saramies, P.E. Schwarz, W.H. Sheu, A.R. Shuldiner, A. Siegbahn, T.D. Spector, K. Stefansson, D.P. Strachan, B.O. Tayo, E. Tremoli, J. Tuomilehto, M. Uusitupa, C.M. van Duijn, P. Vollenweider, L. Wallentin, N.J. Wareham, J.B. Whitfield, B.H. Wolffenbuttel, J.M. Ordovas, E. Boerwinkle, C.N. Palmer, U. Thorsteinsdottir, D.I. Chasman, J.I. Rotter, P.W. Franks, S. Ripatti, L.A. Cupples, M.S. Sandhu, S.S. Rich, M. Boehnke, and P. Deloukas Discovery and refinement of loci associated with lipid levels Nat Genet 45 2013 1274 1283
18. R. Do, C.J. Willer, E.M. Schmidt, S. Sengupta, C. Gao, G.M. Peloso, S. Gustafsson, S. Kanoni, A. Ganna, J. Chen, M.L. Buchkovich, S. Mora, J.S. Beckmann, J.L. Bragg-Gresham, H.Y. Chang, A. Demirkan, H.M. Den Hertog, L.A. Donnelly, G.B. Ehret, T. Esko, M.F. Feitosa, T. Ferreira, K. Fischer, P. Fontanillas, R.M. Fraser, D.F. Freitag, D. Gurdasani, K. Heikkila, E. Hypponen, A. Isaacs, A.U. Jackson, A. Johansson, T. Johnson, M. Kaakinen, J. Kettunen, M.E. Kleber, X. Li, J. Luan, L.P. Lyytikainen, P.K. Magnusson, M. Mangino, E. Mihailov, M.E. Montasser, M. Muller-Nurasyid, I.M. Nolte, J.R. O'Connell, C.D. Palmer, M. Perola, A.K. Petersen, S. Sanna, R. Saxena, S.K. Service, S. Shah, D. Shungin, C. Sidore, C. Song, R.J. Strawbridge, I. Surakka, T. Tanaka, T.M. Teslovich, G. Thorleifsson, E.G. Van den Herik, B.F. Voight, K.A. Volcik, L.L. Waite, A. Wong, Y. Wu, W. Zhang, D. Absher, G. Asiki, I. Barroso, L.F. Been, J.L. Bolton, L.L. Bonnycastle, P. Brambilla, M.S. Burnett, G. Cesana, M. Dimitriou, A.S. Doney, A. Doring, P. Elliott, S.E. Epstein, G.I. Eyjolfsson, B. Gigante, M.O. Goodarzi, H. Grallert, M.L. Gravito, C.J. Groves, G. Hallmans, A.L. Hartikainen, C. Hayward, D. Hernandez, A.A. Hicks, H. Holm, Y.J. Hung, T. Illig, M.R. Jones, P. Kaleebu, J.J. Kastelein, K.T. Khaw, E. Kim, N. Klopp, P. Komulainen, M. Kumari, C. Langenberg, T. Lehtimaki, S.Y. Lin, J. Lindstrom, R.J. Loos, F. Mach, W.L. McArdle, C. Meisinger, B.D. Mitchell, G. Muller, R. Nagaraja, N. Narisu, T.V. Nieminen, R.N. Nsubuga, I. Olafsson, K.K. Ong, A. Palotie, T. Papamarkou, C. Pomilla, A. Pouta, D.J. Rader, M.P. Reilly, P.M. Ridker, F. Rivadeneira, I. Rudan, A. Ruokonen, N. Samani, H. Scharnagl, J. Seeley, K. Silander, A. Stancakova, K. Stirrups, A.J. Swift, L. Tiret, A.G. Uitterlinden, L.J. van Pelt, S. Vedantam, N. Wainwright, C. Wijmenga, S.H. Wild, G. Willemsen, T. Wilsgaard, J.F. Wilson, E.H. Young, J.H. Zhao, L.S. Adair, D. Arveiler, T.L. Assimes, S. Bandinelli, F. Bennett, M. Bochud, B.O. Boehm, D.I. Boomsma, I.B. Borecki, S.R. Bornstein, P. Bovet, M. Burnier, H. Campbell, A. Chakravarti, J.C. Chambers, Y.D. Chen, F.S. Collins, R.S. Cooper, J. Danesh, G. Dedoussis, U. de Faire, A.B. Feranil, J. Ferrieres, L. Ferrucci, N.B. Freimer, C. Gieger, L.C. Groop, V. Gudnason, U. Gyllensten, A. Hamsten, T.B. Harris, A. Hingorani, J.N. Hirschhorn, A. Hofman, G.K. Hovingh, C.A. Hsiung, S.E. Humphries, S.C. Hunt, K. Hveem, C. Iribarren, M.R. Jarvelin, A. Jula, M. Kahonen, J. Kaprio, A. Kesaniemi, M. Kivimaki, J.S. Kooner, P.J. Koudstaal, R.M. Krauss, D. Kuh, J. Kuusisto, K.O. Kyvik, M. Laakso, T.A. Lakka, L. Lind, C.M. Lindgren, N.G. Martin, W. Marz, M.I. McCarthy, C.A. McKenzie, P. Meneton, A. Metspalu, L. Moilanen, A.D. Morris, P.B. Munroe, I. Njolstad, N.L. Pedersen, C. Power, P.P. Pramstaller, J.F. Price, B.M. Psaty, T. Quertermous, R. Rauramaa, D. Saleheen, V. Salomaa, D.K. Sanghera, J. Saramies, P.E. Schwarz, W.H. Sheu, A.R. Shuldiner, A. Siegbahn, T.D. Spector, K. Stefansson, D.P. Strachan, B.O. Tayo, E. Tremoli, J. Tuomilehto, M. Uusitupa, C.M. van Duijn, P. Vollenweider, L. Wallentin, N.J. Wareham, J.B. Whitfield, B.H. Wolffenbuttel, D. Altshuler, J.M. Ordovas, E. Boerwinkle, C.N. Palmer, U. Thorsteinsdottir, D.I. Chasman, J.I. Rotter, P.W. Franks, S. Ripatti, L.A. Cupples, M.S. Sandhu, and S.S. Rich Common variants associated with plasma triglycerides and risk for coronary artery disease Nat Genet 45 2013 1345 1352
19. A.B. Jorgensen, R. Frikke-Schmidt, A.S. West, P. Grande, B.G. Nordestgaard, and A. Tybjaerg-Hansen Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction Eur Heart J 34 2013 1826 1833
20. A. Varbo, M. Benn, A. Tybjaerg-Hansen, A.B. Jorgensen, R. Frikke-Schmidt, and B.G. Nordestgaard Remnant cholesterol as a causal risk factor for ischemic heart disease J Am Coll Cardiol 61 2013 427 436
21. A. Varbo, M. Benn, A. Tybjaerg-Hansen, and B.G. Nordestgaard Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation Circulation 128 2013 1298 1309
22. M. Thomsen, A. Varbo, A. Tybjaerg-Hansen, and B.G. Nordestgaard Low nonfasting triglycerides and reduced all-cause mortality: a Mendelian randomization study Clin Chem 60 2014 737 746
23. M.V. Holmes, F.W. Asselbergs, T.M. Palmer, F. Drenos, M.B. Lanktree, C.P. Nelson, C.E. Dale, S. Padmanabhan, C. Finan, D.I. Swerdlow, V. Tragante, E.P. van Iperen, S. Sivapalaratnam, S. Shah, C.C. Elbers, T. Shah, J. Engmann, C. Giambartolomei, J. White, D. Zabaneh, R. Sofat, S. McLachlan, P.A. Doevendans, A.J. Balmforth, A.S. Hall, K.E. North, B. Almoguera, R.C. Hoogeveen, M. Cushman, M. Fornage, S.R. Patel, S. Redline, D.S. Siscovick, M.Y. Tsai, K.J. Karczewski, M.H. Hofker, W.M. Verschuren, M.L. Bots, Y.T. van der Schouw, O. Melander, A.F. Dominiczak, R. Morris, Y. Ben-Shlomo, J. Price, M. Kumari, J. Baumert, A. Peters, B. Thorand, W. Koenig, T.R. Gaunt, S.E. Humphries, R. Clarke, H. Watkins, M. Farrall, J.G. Wilson, S.S. Rich, P.I. de Bakker, L.A. Lange, S.G. Davey, A.P. Reiner, P.J. Talmud, M. Kivimaki, D.A. Lawlor, F. Dudbridge, N.J. Samani, B.J. Keating, A.D. Hingorani, and J.P. Casas Mendelian randomization of blood lipids for coronary heart disease Eur Heart J 36 2015 539 550
24. H.H. Wittrup, A. Tybjaerg-Hansen, and B.G. Nordestgaard Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis Circulation 99 1999 2901 2907
25. W.C. Breckenridge, J.A. Little, G. Steiner, A. Chow, and M. Poapst Hypertriglyceridemia associated with deficiency of apolipoprotein C-II N Engl J Med 298 1978 1265 1273
26. M. Reina, J.D. Brunzell, and S.S. Deeb Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes J Lipid Res 33 1992 1823 1832
27. M.R. Irvin, D. Zhi, R. Joehanes, M. Mendelson, S. Aslibekyan, S.A. Claas, K.S. Thibeault, N. Patel, K. Day, L.W. Jones, L. Liang, B.H. Chen, C. Yao, H.K. Tiwari, J.M. Ordovas, D. Levy, D. Absher, and D.K. Arnett Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study Circulation 130 2014 565 572
28. A.E. Taylor, N.M. Davies, J.J. Ware, T. VanderWeele, G.D. Smith, and M.R. Munafo Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates Econ Hum Biol 13 2014 99 106
29. B.F. Voight, G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M.K. Jensen, G. Hindy, H. Holm, E.L. Ding, T. Johnson, H. Schunkert, N.J. Samani, R. Clarke, J.C. Hopewell, J.F. Thompson, M. Li, G. Thorleifsson, C. Newton-Cheh, K. Musunuru, J.P. Pirruccello, D. Saleheen, L. Chen, A. Stewart, A. Schillert, U. Thorsteinsdottir, G. Thorgeirsson, S. Anand, J.C. Engert, T. Morgan, J. Spertus, M. Stoll, K. Berger, N. Martinelli, D. Girelli, P.P. McKeown, C.C. Patterson, S.E. Epstein, J. Devaney, M.S. Burnett, V. Mooser, S. Ripatti, I. Surakka, M.S. Nieminen, J. Sinisalo, M.L. Lokki, M. Perola, A. Havulinna, U. de Faire, B. Gigante, E. Ingelsson, T. Zeller, P. Wild, P.I. de Bakker, O.H. Klungel, A.H. Maitland-van der Zee, B.J. Peters, B.A. de, D.E. Grobbee, P.W. Kamphuisen, V.H. Deneer, C.C. Elbers, N.C. Onland-Moret, M.H. Hofker, C. Wijmenga, W.M. Verschuren, J.M. Boer, Y.T. van der Schouw, A. Rasheed, P. Frossard, S. Demissie, C. Willer, R. Do, J.M. Ordovas, G.R. Abecasis, M. Boehnke, K.L. Mohlke, M.J. Daly, C. Guiducci, N.P. Burtt, A. Surti, E. Gonzalez, S. Purcell, S. Gabriel, J. Marrugat, J. Peden, J. Erdmann, P. Diemert, C. Willenborg, I.R. Konig, M. Fischer, C. Hengstenberg, A. Ziegler, I. Buysschaert, D. Lambrechts, F. Van de Werf, K.A. Fox, N.E. El Mokhtari, D. Rubin, J. Schrezenmeir, S. Schreiber, A. Schafer, J. Danesh, S. Blankenberg, R. Roberts, R. McPherson, H. Watkins, A.S. Hall, K. Overvad, E. Rimm, E. Boerwinkle, A. Tybjaerg-Hansen, L.A. Cupples, M.P. Reilly, O. Melander, P.M. Mannucci, D. Ardissino, D. Siscovick, R. Elosua, K. Stefansson, C.J. O'Donnell, V. Salomaa, D.J. Rader, L. Peltonen, S.M. Schwartz, D. Altshuler, and S. Kathiresan Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study Lancet 380 2012 572 580
30. R. Frikke-Schmidt, B.G. Nordestgaard, M.C. Stene, A.A. Sethi, A.T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease JAMA 299 2008 2524 2532
31. T.H. Johannsen, P.R. Kamstrup, R.V. Andersen, G.B. Jensen, H. Sillesen, A. Tybjaerg-Hansen, and B.G. Nordestgaard Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease J Clin Endocrinol Metab 94 2009 1264 1273
32. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, and B. Brewer Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
33. G.G. Schwartz, A.G. Olsson, M. Abt, C.M. Ballantyne, P.J. Barter, J. Brumm, B.R. Chaitman, I.M. Holme, D. Kallend, L.A. Leiter, E. Leitersdorf, J.J. McMurray, H. Mundl, S.J. Nicholls, P.K. Shah, J.C. Tardif, and R.S. Wright Effects of dalcetrapib in patients with a recent acute coronary syndrome N Engl J Med 367 2012 2089 2099
34. D. Hilleman, and A. Smer Prescription omega-3 fatty acid products and dietary supplements are not interchangeable Manag Care 25 2016 46 52
35. Vascepa [package Insert] 2015 Amarin Pharma Inc Bedminster, NJ
36. W.S. Harris, H.N. Ginsberg, N. Arunakul, N.S. Shachter, S.L. Windsor, M. Adams, L. Berglund, and K. Osmundsen Safety and efficacy of Omacor in severe hypertriglyceridemia J Cardiovasc Risk 4 1997 385 391
37. H.J. Pownall, D. Brauchi, C. Kilinc, K. Osmundsen, Q. Pao, C. Payton-Ross, A.M. Gotto Jr., and C.M. Ballantyne Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins Atherosclerosis 143 1999 285 297
38. M.H. Davidson, E.A. Stein, H.E. Bays, K.C. Maki, R.T. Doyle, R.A. Shalwitz, C.M. Ballantyne, and H.N. Ginsberg Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study Clin Ther 29 2007 1354 1367
39. H.E. Bays, C.M. Ballantyne, J.J. Kastelein, J.L. Isaacsohn, R.A. Braeckman, and P.N. Soni Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial) Am J Cardiol 108 2011 682 690
40. C.M. Ballantyne, H.E. Bays, J.J. Kastelein, E. Stein, J.L. Isaacsohn, R.A. Braeckman, and P.N. Soni Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study) Am J Cardiol 110 2012 984 992
41. J.J.P. Kastelein, K.C. Maki, A. Susekov, M. Ezhov, B.G. Nordestgaard, B.N. Machielse, D. Kling, and M.H. Davidson Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial J Clin Lipidol 8 2014 94 108
42. K.C. Maki, D.G. Orloff, S.J. Nicholls, R.L. Dunbar, E.M. Roth, D. Curcio, J. Johnson, D. Kling, and M.H. Davidson A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial) Clin Ther 35 2013 1400 1411
43. Lovaza [package Insert] 2014 GlaxoSmithKline Research Triangle Park, NC
44. Epanova [package Insert] 2014 AstraZeneca Pharmaceuticals LP Wilmington, DE
45. Omtryg [package Insert] 2014 Trygg Pharma, Inc. Arlington, VA
46. C.M. Ballantyne, H.E. Bays, R.A. Braeckman, S. Philip, W.G. Stirtan, R.T. Doyle Jr., P.N. Soni, and R.A. Juliano Icosapent ethyl (eicosapentaenoic acid ethyl ester): effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies [abstract] Circulation 130 suppl 2 2014 A16803
47. M.K. Ito Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature Atherosclerosis 242 2015 647 656
48. M.H. Davidson, R.S. Rosenson, K.C. Maki, S.J. Nicholls, C.M. Ballantyne, T. Mazzone, D.M. Carlson, L.A. Williams, M.T. Kelly, H.S. Camp, A. Lele, and J.C. Stolzenbach Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST) Arterioscler Thromb Vasc Biol 34 2014 1298 1306
49. D. Mozaffarian, and J.H. Wu Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events J Am Coll Cardiol 58 2011 2047 2067
50. Manku MS, Best practices: why EPA only? Understanding the distinctions between high-dose prescription EPA-only drug intervention for treating disease versus omega-3 dietary supplementation for promotion of health. Intern Med News. December 2015. Supplement.
51. K.M. Borow, J.R. Nelson, and R.P. Mason Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis Atherosclerosis 242 2015 357 366
52. C.P. Cannon, M.A. Blazing, R.P. Giugliano, A. McCagg, J.A. White, P. Theroux, H. Darius, B.S. Lewis, T.O. Ophuis, J.W. Jukema, G.M. De Ferrari, W. Ruzyllo, L.P. De, K. Im, E.A. Bohula, C. Reist, S.D. Wiviott, A.M. Tershakovec, T.A. Musliner, E. Braunwald, and R.M. Califf Ezetimibe added to statin therapy after acute coronary syndromes N Engl J Med 372 2015 2387 2397
53. D.J. Blom, T. Hala, M. Bolognese, M.J. Lillestol, P.D. Toth, L. Burgess, R. Ceska, E. Roth, M.J. Koren, C.M. Ballantyne, M.L. Monsalvo, K. Tsirtsonis, J.B. Kim, R. Scott, S.M. Wasserman, and E.A. Stein A 52-week placebo-controlled trial of evolocumab in hyperlipidemia N Engl J Med 370 2014 1809 1819
54. J.G. Robinson, M. Farnier, M. Krempf, J. Bergeron, G. Luc, M. Averna, E.S. Stroes, G. Langslet, F.J. Raal, M.E. Shahawy, M.J. Koren, N.E. Lepor, C. Lorenzato, R. Pordy, U. Chaudhari, and J.J. Kastelein Efficacy and safety of alirocumab in reducing lipids and cardiovascular events N Engl J Med 372 2015 1489 1499
55. M.S. Sabatine, R.P. Giugliano, S.D. Wiviott, F.J. Raal, D.J. Blom, J. Robinson, C.M. Ballantyne, R. Somaratne, J. Legg, S.M. Wasserman, R. Scott, M.J. Koren, and E.A. Stein Efficacy and safety of evolocumab in reducing lipids and cardiovascular events N Engl J Med 372 2015 1500 1509